Support Local Journalism, Join the SA Current Press Club.

U.S. Rep. Doggett Asks White House for Price Controls on Coronavirus Drugs 

Lloyd Doggett speaks at a Washington press conference. - WIKIMEDIA COMMONS
  • Wikimedia Commons
  • Lloyd Doggett speaks at a Washington press conference.
San Antonio-Austin Congressman Lloyd Doggett sent a letter to President Trump this week asking him to rein in the price of any coronavirus vaccine that arises from federal research.

The letter — co-written with fellow U.S. Rep. Jan Schakowsky, D.-Illinois, and signed by 46 other Democratic House members — asks Trump's to “ensure that any vaccine or treatment developed with U.S. taxpayer dollars be accessible, available and affordable.” No Republicans co-signed.

According to the letter, those goals are unattainable unless the National Institutes of Health, which funds the majority of coronavirus research, grants licenses to multiple pharmaceutical manufacturers rather than a single entity — and limits what the companies can charge.

"We should not grant any manufacturer a blank check to monopolize a coronavirus vaccine or treatment developed with public, taxpayer support," the letter states. "Without aggressive action to protect public health, we are fearful that Americans and people in lower- and middle-income countries will not be adequately protected against current and future coronavirus outbreaks."

The NIH alone has spent nearly $700 million in coronavirus R&D, including COVID-19, according to a recent Public Citizen study.

Vaccine price controls aren't a new concern for Doggett, who's advocated since 2016 that the NIH shouldn't give away taxpayer-funded research to drug companies without constraining their profit-taking. He sent a similar letter in 2017, asking that a potential Zika virus also include price controls.

This week's letter also includes a reference to Trump's often-repeated — and still undelivered — promise to hold down prescription drug prices.

"You have repeatedly called for action to lower drug prices and know that unjustifiably high drug prices are one of the most pressing public health concerns we face today," Doggett and Schakowsky write.

Stay on top of San Antonio news and views. Sign up for our Weekly Headlines Newsletter.

Support Local Journalism.
Join the San Antonio Current Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state. Our readers helped us continue this coverage in 2020, and we are so grateful for the support.

Help us keep this coverage going in 2021. Whether it's a one-time acknowledgement of this article or an ongoing membership pledge, your support goes to local-based reporting from our small but mighty team.

Join the San Antonio Press Club for as little as $5 a month.

Read the Digital Print Issue

January 26, 2022

View more issues


Join SA Current Newsletters

Sign Up Now

Subscribe now to get the latest news delivered right to your inbox.


© 2022 San Antonio Current

Website powered by Foundation